This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Oct 20;140(16):1750-1751.

doi: 10.1182/blood.2022018081.

Optimized CD19/CD22/CD3 antibody

Dafne Müller¹

Affiliations

PMID: 36264591
DOI: 10.1182/blood.2022018081

Free article

Comment

Optimized CD19/CD22/CD3 antibody

Dafne Müller. Blood. 2022.

Free article

. 2022 Oct 20;140(16):1750-1751.

doi: 10.1182/blood.2022018081.

Author

Dafne Müller¹

Affiliation

¹ University of Stuttgart.

PMID: 36264591
DOI: 10.1182/blood.2022018081

No abstract available

PubMed Disclaimer

Comment on

A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL.
Zhao L, Li S, Wei X, Qi X, Liu D, Liu L, Wen F, Zhang JS, Wang F, Liu ZL, Cao YJ. Zhao L, et al. Blood. 2022 Oct 20;140(16):1790-1802. doi: 10.1182/blood.2022016243. Blood. 2022. PMID: 35981465

Publication types

Actions

MeSH terms

Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Optimized CD19/CD22/CD3 antibody

Affiliation

Optimized CD19/CD22/CD3 antibody

Author

Affiliation

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources